| Summary: | OBJECTIVE: Evoked potentials are used in the functional assessment of sensory and motor pathways. Conflicting results have been reported in different studies about the value of evoked potentials in demyelinating diseases. Over 80% of patients with multiple sclerosis present with a relapsing–remitting form of the disease. In this study we aimed to examine the value of each evoked potential to demonstrate the demyelinating lesions in a homogenous group of patients with relapsing remitting multiple sclerosis. We also aimed to examine the correlation between clinical status and evoked potential abnormalities.
METHODS: Twenty patients with relapsing remitting multiple sclerosis and ten healthy volunteers were included in the study to evaluate the value of evoked potentials in a homogenous group. Visual, somatosensory and motor evoked potentials were measured and EDSS scores of the patients were calculated.
RESULTS: Of 20 patients, 15 patients(75%) had VEP abnormality, 14 patients (70%) had MEP abnormality and 12 patients (60%) had tibial SEP abnormality. All patients had at least one abnormal evoked potential measurement. The abnormality of evoked potentials also had a correlation with high EDSS scores.
CONCLUSION: We concluded that evoked potentials, especially used in combination, are good markers to show the nervous damage in patients with multiple sclerosis.
|
|---|
